The PurpleLab®

Payer/Provider

Whitepapers

The COVID-19 pandemic underscored the necessity for healthcare organizations to adapt swiftly. This was particularly evident with the rapid adoption of telehealth. For instance, in the first quarter of 2020, telehealth visits surged by 50% compared to 2019. As COVID-19 becomes endemic, healthcare leaders face crucial decisions on the strategic use of telehealth versus in-person…

Articles

Healthcare today is evolving into precision medicine, or what the FDA refers to as personalized medicine.  To stay competitive in the constantly shifting healthcare landscape, organizations across the healthcare ecosystem must embrace this targeted approach and leverage the tools needed to make safe decisions for their patients or populations. By unlocking insights provided from advanced…

Articles

Payers are continuously looking to improve health outcomes. Removing barriers to care and improving care access through analyzing social determinants of health (SDOH) data is a key strategy. The social determinants of health (SDOH) include education, housing, transportation, income as well as other factors including where people are born, raised, live and work that impact their…

Webinars

In the ever-evolving landscape of healthcare, deciphering claims data has proven to be a formidable challenge for payers and providers alike. How does PurpleLab’s data help health plans transform their claims data into actionable insights? Watch this webinar with Dr. Russell Robbins, CMIO at PurpleLab, and Dr. Aaron Novotny, Director of Health Economics at Arkansas…

Solution Sheets

CLEAR Claims Payer & Provider Payer & Provider Download

Articles

In 2019, the National Multiple Sclerosis Society published a series of findings with updated prevalence of the disease. Current estimates place the number of people diagnosed with Multiple Sclerosis (MS) at one million people in the US; double previously reported figures. It is a costly and chronic disease without an exact known cause or biomarker,…

Articles

February is low-vision month, and at PurpleLab we are focusing on Age-Related Macular Degeneration (AMD), one of the diseases responsible for this condition.  According to the Centers for Disease Control’s (CDC) Vision and Eye Health Surveillance System (VEHSS) about twenty million Americans aged forty and older are living with AMD; 1.5 million of which are…

Articles

When the pandemic struck in 2019, there were more than 51 million Americans experiencing some type of mental illness.